Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells

Mei Yang1, Jingqi Chen, Fang Su

  • 1Breast Tumor Center, Sun-Yat-Sen Memorial Hospital, Sun-Yat-Sen University, Guangzhou, PR China.

Molecular Cancer
|September 24, 2011
PubMed
Abstract

Insights

Tumor-associated macrophages (TAMs) promote breast cancer invasion by sending microRNAs (miRNAs) within exosomes to cancer cells. Inhibiting miR-223 in TAMs reduced cancer cell invasiveness, revealing a key mechanism in metastasis.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Tumor-associated macrophages (TAMs), induced by IL-4, enhance breast cancer invasion and metastasis.
  • Mechanisms of macrophage-tumor cell interaction driving metastasis are not fully understood.
  • Exosomes mediate cell-cell communication via microRNA (miRNA) transfer.

Purpose of the Study:

  • To investigate if macrophage-secreted exosomes deliver miRNAs that promote breast cancer cell invasion.
  • To elucidate the role of specific miRNAs in TAM-mediated breast cancer metastasis.

Main Methods:

  • Co-culture system of IL-4-activated macrophages and breast cancer cells.
  • Tracking of fluorescently labeled miRNAs transferred from macrophages to cancer cells via exosomes.
  • Quantification of miR-223 levels in exosomes and breast cancer cells.
  • Assessment of breast cancer cell invasiveness after miR-223 inhibition in macrophages.

Main Results:

  • Exosomes from IL-4-activated macrophages transferred miRNAs to breast cancer cells without direct contact.
  • miR-223, specific to IL-4-activated macrophages, was elevated in co-cultured breast cancer cells.
  • Inhibition of miR-223 in macrophages reduced breast cancer cell invasiveness.
  • miR-223 was found to promote breast cancer cell invasion through the Mef2c-β-catenin pathway.

Conclusions:

  • Macrophages regulate breast cancer cell invasiveness via exosome-mediated transfer of oncogenic miRNAs.
  • This study reveals a novel mechanism by which TAMs contribute to breast cancer metastasis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...